 | Bicalutamide | IC50 | 330.0 [1] |
| Bicalutamide | Ki | 19.0 [1], 35.0 [2], 64.0 [3] |
 | Androstanolone | IC50 | 2.1 [1], 13.1 [2], 10000.0 [3] |
 | Hydroxyflutamide | IC50 | 43.0 [1] |
| Hydroxyflutamide | Ki | 2.0 [1], 43.0 [2] |
 | Mifepristone | IC50 | 7.8 [1] |
| Mifepristone | Ki | 0.65 [1] |
 | Progesterone | IC50 | 37.0 [1] |
 | Testosterone | IC50 | 2.7 [1], 3.9 [2], 4.27 [3] |
| Testosterone | Ki | 29.0 [1] |
 | Flutamide | IC50 | 580.0 [1] |
| Flutamide | Ki | 1300.0 [1], 3700.0 [2] |
 | (R)-Bicalutamide | IC50 | 270.0 [1], 490.0 [2] |
| (R)-Bicalutamide | Ki | 70.0 [1], 151.0 [2], 3700.0 [3] |
 | 6-(Bis-(2,2,2-trifluoroethyl)amino)-4-trifluoromethyl-1H-quinolin-2-one | IC50 | 10000.0 [1] |
| 6-(Bis-(2,2,2-trifluoroethyl)amino)-4-trifluoromethyl-1H-quinolin-2-one | Ki | 1.5 [1], 4.6 [2] |
 | Medroxyprogesterone acetate | IC50 | 6.1 [1] |
| Medroxyprogesterone acetate | Ki | 2.9 [1] |
 | Enzalutamide | IC50 | 50.0 [1], 90.0 [2], 361.0 [3], 1260.0 [4], 100000.0 [5] |
| Enzalutamide | Ki | 28.2 [1] |
 | (2R,6S)-4-[3-(Trifluoromethyl)phenyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione | IC50 | 7.0 [1], 127.0 [2], 152.0 [3], 205.0 [4] |
| (2R,6S)-4-[3-(Trifluoromethyl)phenyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione | Ki | 3.4 [1], 319.0 [2], 360.0 [3] |
 | Spironolactone | IC50 | 120.0 [1], 523.0 [2], 670.0 [3] |
| Spironolactone | Ki | 39.4 [1] |
 | 4-(3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile | IC50 | 32.0 [1], 40.0 [2] |
 | 6-Ethyl-4-(trifluoromethyl)-6,7,8,9-tetrahydro-1H-pyrido[3,2-g]quinolin-2-one | IC50 | 4580.0 [1], 7481.0 [2], 10000.0 [3] |
| 6-Ethyl-4-(trifluoromethyl)-6,7,8,9-tetrahydro-1H-pyrido[3,2-g]quinolin-2-one | Ki | 7.0 [1], 11.0 [2], 17.0 [3] |
 | 8,8-Dimethyl-4-trifluoromethyl-6,7,8,9-tetrahydro-1H-pyrido[3,2-g]quinolin-2-one | IC50 | 27.0 [1] |
| 8,8-Dimethyl-4-trifluoromethyl-6,7,8,9-tetrahydro-1H-pyrido[3,2-g]quinolin-2-one | Ki | 26.0 [1] |
 | (2S,6R)-4-[4-Nitro-3-(trifluoromethyl)phenyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione | IC50 | 12.0 [1], 114.0 [2] |
| (2S,6R)-4-[4-Nitro-3-(trifluoromethyl)phenyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione | Ki | 2.0 [1], 5.0 [2], 117.0 [3] |
 | Dexamethasone | IC50 | 1000.0 [1], 4000.0 [2], 20000.0 [3] |
| Dexamethasone | Ki | 1410.0 [1] |
 | Prednisolone | IC50 | 2000.0 [1], 34000.0 [2] |
| Prednisolone | Ki | 2520.0 [1], 2760.0 [2], 2762.0 [3] |
 | Bms-564929 | Ki | 1.4 [1], 2.1 [2], 2.11 [3], 14.0 [4] |
 | 1-Imidazolidinepropanesulfonamide, 3-(3-chloro-4-cyanophenyl)-5,5-dimethyl-4-oxo-2-thioxo- | IC50 | 10.0 [1], 12.0 [2], 200.0 [3], 410.0 [4], 440.0 [5] |
 | (2S,6R)-4-[3-(Trifluoromethyl)phenyl]-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | IC50 | 35.0 [1], 410.0 [2], 744.0 [3] |
| (2S,6R)-4-[3-(Trifluoromethyl)phenyl]-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | Ki | 7.0 [1], 632.0 [2] |
 | (2R,6S)-4-(8-Hydroxyquinolin-5-yl)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | IC50 | 418.0 [1], 1790.0 [2], 3639.0 [3] |
| (2R,6S)-4-(8-Hydroxyquinolin-5-yl)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | Ki | 32.0 [1], 162.0 [2] |
 | (2S,6R)-4-[3,5-Bis(trifluoromethyl)phenyl]-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | IC50 | 72.0 [1], 198.0 [2], 1746.0 [3] |
| (2S,6R)-4-[3,5-Bis(trifluoromethyl)phenyl]-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | Ki | 24.0 [1], 401.0 [2] |
 | (2R,6S)-4-(3,5-Dichlorophenyl)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | IC50 | 41.0 [1], 180.0 [2], 307.0 [3] |
| (2R,6S)-4-(3,5-Dichlorophenyl)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | Ki | 6.0 [1], 158.0 [2] |
 | (2S,6R)-4-Naphthalen-2-yl-4-azatricyclo[5.2.1.02,6]decane-3,5-dione | IC50 | 84.0 [1], 265.0 [2], 1200.0 [3] |
| (2S,6R)-4-Naphthalen-2-yl-4-azatricyclo[5.2.1.02,6]decane-3,5-dione | Ki | 11.0 [1], 284.0 [2] |
 | (2R,6S)-4-(4-Nitrophenyl)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | IC50 | 30.0 [1], 179.0 [2], 664.0 [3] |
| (2R,6S)-4-(4-Nitrophenyl)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | Ki | 12.0 [1], 192.0 [2] |
 | (2S,6R)-4-Quinolin-7-yl-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | IC50 | 52.0 [1], 234.0 [2], 1038.0 [3] |
| (2S,6R)-4-Quinolin-7-yl-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | Ki | 13.0 [1], 530.0 [2] |
 | (2S,6R)-4-Naphthalen-2-yl-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | IC50 | 84.0 [1], 265.0 [2], 1210.0 [3] |
| (2S,6R)-4-Naphthalen-2-yl-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | Ki | 11.0 [1], 284.0 [2] |
 | (2R,6S)-4-(3-Chloro-4-fluorophenyl)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | IC50 | 33.0 [1], 132.0 [2], 517.0 [3] |
| (2R,6S)-4-(3-Chloro-4-fluorophenyl)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | Ki | 2.0 [1], 177.0 [2] |
 | (2S,6R)-4-(3,4-Dimethylphenyl)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | IC50 | 10.0 [1], 96.0 [2], 2014.0 [3] |
| (2S,6R)-4-(3,4-Dimethylphenyl)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | Ki | 3.4 [1], 400.0 [2] |
 | (2R,6R)-8-Methyl-4-(4-nitronaphthalen-1-yl)-4,8-diazatricyclo[5.2.2.02,6]undec-10-ene-3,5,9-trione | IC50 | 631.0 [1], 4030.0 [2], 8460.0 [3] |
| (2R,6R)-8-Methyl-4-(4-nitronaphthalen-1-yl)-4,8-diazatricyclo[5.2.2.02,6]undec-10-ene-3,5,9-trione | Ki | 115.0 [1], 5000.0 [2] |
 | (2R,6S,8S,10R)-4-[3-(Trifluoromethyl)phenyl]-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-ene-3,5-dione | IC50 | 30.0 [1], 148.0 [2], 1700.0 [3] |
| (2R,6S,8S,10R)-4-[3-(Trifluoromethyl)phenyl]-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-ene-3,5-dione | Ki | 9.0 [1], 3200.0 [2] |
 | (2R,6S)-4-(3,4-Dichlorophenyl)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | IC50 | 41.0 [1], 180.0 [2], 307.0 [3] |
| (2R,6S)-4-(3,4-Dichlorophenyl)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | Ki | 6.0 [1], 158.0 [2] |
 | (2R,6S)-4-[3-(Trifluoromethyl)phenyl]-4-azatricyclo[5.2.2.02,6]undec-8-ene-3,5-dione | IC50 | 0.4 [1], 66.0 [2], 196.0 [3] |
| (2R,6S)-4-[3-(Trifluoromethyl)phenyl]-4-azatricyclo[5.2.2.02,6]undec-8-ene-3,5-dione | Ki | 19.0 [1], 100.0 [2] |
 | (2S,6R)-4-[3-(Trifluoromethyl)phenyl]-4-azatricyclo[5.3.2.02,6]dodecane-3,5-dione | IC50 | 23.0 [1], 179.0 [2], 658.0 [3] |
| (2S,6R)-4-[3-(Trifluoromethyl)phenyl]-4-azatricyclo[5.3.2.02,6]dodecane-3,5-dione | Ki | 20.0 [1], 2810.0 [2] |
 | Eplerenone | IC50 | 10000.0 [1], 20000.0 [2] |
 | Onapristone | IC50 | 269.0 [1] |
| Onapristone | Ki | 100.0 [1] |
 | 4-(((1R,2S)-2-Cyanocyclohexyl)oxy)-2-(trifluoromethyl)benzonitrile | IC50 | 12.0 [1], 60.0 [2] |
 | 4-[(7r,7As)-7-Hydroxy-1,3-Dioxotetrahydro-1h-Pyrrolo[1,2-C]imidazol-2(3h)-Yl]-1-Naphthonitrile | Ki | 3.2 [1] |
 | (2R)-2-Methyl-1-(2,2,2-trifluoroethyl)-9-(trifluoromethyl)-3,6-dihydro-2H-pyrido[3,2-g][1,4]benzoxazin-7-one | IC50 | 70.0 [1] |
| (2R)-2-Methyl-1-(2,2,2-trifluoroethyl)-9-(trifluoromethyl)-3,6-dihydro-2H-pyrido[3,2-g][1,4]benzoxazin-7-one | Ki | 0.9 [1], 7.1 [2] |
 | 6-{Methyl[(1R)-1-phenylethyl]amino}-4-(trifluoromethyl)pyridine-3-carbonitrile | IC50 | 20.0 [1], 45.0 [2] |
 | 4-(2-Hydroxyphenyl)-2-(trifluoromethyl)benzonitrile | IC50 | 0.02 [1], 39.9 [2] |
 | 2,2-Dimethyl-6-(trifluoromethyl)-1,9-dihydropyrido[3,2-g]quinolin-8-one | IC50 | 27.0 [1], 58.0 [2] |
| 2,2-Dimethyl-6-(trifluoromethyl)-1,9-dihydropyrido[3,2-g]quinolin-8-one | Ki | 73.0 [1], 86.0 [2] |
 | 3-Chloro-4-(o-tolyloxy)benzonitrile | IC50 | 46.0 [1], 64.0 [2] |
 | 4-(Trifluoromethyl)-6-(diethylamino)quinoline-2(1H)-one | IC50 | 1000.0 [1], 10000.0 [2] |
| 4-(Trifluoromethyl)-6-(diethylamino)quinoline-2(1H)-one | Ki | 4.4 [1] |
 | 6-(Dipropylamino)-4-(trifluoromethyl)-1,2-dihydroquinolin-2-one | IC50 | 10000.0 [1] |
| 6-(Dipropylamino)-4-(trifluoromethyl)-1,2-dihydroquinolin-2-one | Ki | 64.0 [1] |
 | 1-[2-(4-Methylphenoxy)ethyl]-2-(2-phenoxyethylsulfanyl)benzimidazole | IC50 | 10000.0 [1], 13100.0 [2], 50000.0 [3] |
 | 4-(2-Fluorophenylthio)-2-(trifluoromethyl)benzonitrile | IC50 | 54.0 [1], 184.0 [2] |
 | 6-[Ethyl(2,2,2-trifluoroethyl)amino]-4-(trifluoromethyl)-1,2-dihydroquinolin-2-one | IC50 | 10000.0 [1] |
| 6-[Ethyl(2,2,2-trifluoroethyl)amino]-4-(trifluoromethyl)-1,2-dihydroquinolin-2-one | Ki | 7.1 [1] |
 | (2S,6R,10S,11R)-4-(4-Bromo-3-methylphenyl)-10,11-dihydroxy-4-azatricyclo[5.2.2.02,6]undec-8-ene-3,5-dione | IC50 | 59.0 [1], 5240.0 [2] |
| (2S,6R,10S,11R)-4-(4-Bromo-3-methylphenyl)-10,11-dihydroxy-4-azatricyclo[5.2.2.02,6]undec-8-ene-3,5-dione | Ki | 33.0 [1], 432.0 [2] |
 | Estradiol | IC50 | 19.1 [1], 26.0 [2] |
 | Nordihydroguaiaretic acid | IC50 | 10000.0 [1], 38800.0 [2], 50000.0 [3] |
 | Methyltrienolone | IC50 | 0.3 [1], 7.0 [2] |
| Methyltrienolone | Ki | 0.4 [1] |
 | 6-[(2R,5R)-2-Methyl-5-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-4-(trifluoromethyl)-1H-quinolin-2-one | IC50 | 10000.0 [1] |
| 6-[(2R,5R)-2-Methyl-5-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-4-(trifluoromethyl)-1H-quinolin-2-one | Ki | 1.5 [1] |
 | 4-[(1S,7S,7Ar)-1-ethyl-7-hydroxy-3-oxo-5,6,7,7a-tetrahydro-1H-pyrrolo[1,2-c]imidazol-2-yl]-2-chloro-3-methylbenzonitrile | Ki | 0.9 [1] |
 | 1,8-Dichloro-10-[(3-hydroxy-2,4-dimethoxyphenyl)methylidene]anthracen-9-one | IC50 | 170.0 [1], 1135.0 [2], 10000.0 [3] |
 | 10-[(2-Hydroxy-4-methoxyphenyl)methylidene]anthracen-9-one | IC50 | 100.0 [1], 231.8 [2], 10000.0 [3] |
Calculator
